Title : Prospective replication study implicates the catechol-O-methyltransferase Val158Met polymorphism as a biomarker for the response to morphine in patients with cancer.

Pub. Date : 2017 Oct

PMID : 28928973






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Prospective replication study implicates the catechol-O-methyltransferase Val158Met polymorphism as a biomarker for the response to morphine in patients with cancer. Morphine catechol-O-methyltransferase Homo sapiens
2 Previous studies indicate that a single nucleotide polymorphism in the catechol-O-methyltransferase (COMT) gene (rs4680; p.Val158Met) may present as a predictive biomarker for the response to morphine treatment. Morphine catechol-O-methyltransferase Homo sapiens
3 Previous studies indicate that a single nucleotide polymorphism in the catechol-O-methyltransferase (COMT) gene (rs4680; p.Val158Met) may present as a predictive biomarker for the response to morphine treatment. Morphine catechol-O-methyltransferase Homo sapiens
4 The required dose of morphine on day 1 was significantly higher for patients with the G/G genotype of COMT, compared with those with the A/A and A/G genotypes (P=0.013). Morphine catechol-O-methyltransferase Homo sapiens
5 The results of the present study provide additional evidence that the COMT genotype may be a predictive biomarker for the response to morphine treatment. Morphine catechol-O-methyltransferase Homo sapiens